Profound Medical (PROF) Scheduled to Post Earnings on Thursday

Profound Medical (NASDAQ:PROF) is scheduled to be issuing its quarterly earnings data after the market closes on Thursday, May 9th. Analysts expect the company to announce earnings of ($0.31) per share for the quarter.

Profound Medical (NASDAQ:PROF) last announced its earnings results on Thursday, March 7th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.14). Profound Medical had a negative return on equity of 70.18% and a negative net margin of 396.85%. The company had revenue of $2.01 million for the quarter, compared to the consensus estimate of $1.90 million. On average, analysts expect Profound Medical to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Profound Medical Stock Up 2.8 %

PROF opened at $7.62 on Wednesday. Profound Medical has a fifty-two week low of $7.11 and a fifty-two week high of $15.49. The company has a debt-to-equity ratio of 0.16, a current ratio of 6.58 and a quick ratio of 5.48. The firm’s fifty day moving average price is $8.18 and its two-hundred day moving average price is $8.68. The company has a market capitalization of $186.16 million, a P/E ratio of -5.64 and a beta of 0.84.

About Profound Medical

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.